drugset / Trial / NCT05822245
A Study of PER-001 in Participants With Open-Angle Glaucoma
RandomizedSequentialSingle-blindTreatment
Summary
This clinical study has two phases: Phase 1 and Phase 2a. Phase 1 is an open-label, single ascending dose (SAD), while Phase 2a is a randomized, single-masked (participant) with a sham control.
Timeline
- Start
- 2023-05-25
- Primary completion
- 2025-04-20
- Completion
- 2025-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PER-001 | Unknown | — | Intravitreal |